Bogart Wealth’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$461 Buy
+7
New +$545 ﹤0.01% 1846
2026
Q2
– Sell
-32
Closed -$2.38K – 2015
2026
Q1
$2.38K Sell
32
-32
-50% -$2.32K ﹤0.01% 1234
2025
Q4
$4.9K Buy
+64
New +$4.2K ﹤0.01% 1003

Other funds holding BBIO

Bogart Wealth's BBIO Position: Q3 2026 in Review

Bogart Wealth opened a new position in BridgeBio Pharma (BBIO) in Q3 2026: 7 shares worth $461. The stake represents ﹤0.01% of the portfolio and ranks #1846 among its holdings. This is a return to the name: Bogart Wealth previously reported a position in BBIO as recently as Q1 2026.

Bogart Wealth first reported a position in BBIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.9K in Q4 2025. 469 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • Bogart Wealth held 7 shares of BridgeBio Pharma worth $461 as of Q3 2026.
  • BridgeBio Pharma was a new Bogart Wealth position in Q3 2026.
  • BridgeBio Pharma made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #1846 holding.
  • Bogart Wealth first reported a position in BridgeBio Pharma in Q4 2025 and has held it in 3 quarters since.
  • Bogart Wealth's BridgeBio Pharma position peaked at $4.9K in Q4 2025.
  • 469 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.